At present, serum biomarker Alpha fetoprotein (AFP), vascular invasion, and tumor stage are used to predict the recurrence and prognosis of HCC (8); however, these forecasting methods are based on clinical characteristics and do not consider the complex molecular pathogenesis and biological mechanisms involved in HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.